30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Shehnaaz Suliman

Insider profile

Currently holds positions in Ultragenyx Pharmaceutical Inc and Alector Inc

Positions

Position Company Period
Independent Director Ultragenyx Pharmaceutical Inc Jan. 30, 2019 -
President, Chief Operating Officer Alector Inc Dec. 11, 2019 -
Senior Vice President - Corporate Development and Strategy Theravance Biopharma Inc July 31, 2017 - Dec. 31, 2019

Shehnaaz Suliman's trades of Terex Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-16 2026-06-16 PrS Proposed sale
57,632
343.77
US$4,638,912
57,632 343.77 US$4,638,912
2026-05-18 2026-05-18 S Sale
89,234 +8.7%
16.40
US$808,919
89,234 +8.7% 16.40 US$808,919
2026-05-18 2026-05-18 PrS Proposed sale
28,559
328.56
US$186,135
28,559 328.56 US$186,135
2021-12-14 2021-12-13 PlS Planned sale
10,898 -9.6%
21.73
US$236,802
10,898 -9.6% 21.73 US$236,802
2021-12-14 2021-12-13 PlS Planned sale
64,102 -36.1%
21.16
US$1,356,347
64,102 -36.1% 21.16 US$1,356,347
2021-12-14 2021-12-10 PlS Planned sale
8,874 -8.0%
22.33
US$198,192
8,874 -8.0% 22.33 US$198,192
2021-12-14 2021-12-10 PlS Planned sale
66,126 -37.2%
21.69
US$1,433,975
66,126 -37.2% 21.69 US$1,433,975
2021-12-10 2021-12-09 PlS Planned sale
2,643 -2.5%
23.40
US$61,858
2,643 -2.5% 23.40 US$61,858
2021-12-10 2021-12-09 PlS Planned sale
72,357 -40.7%
22.80
US$1,649,986
72,357 -40.7% 22.80 US$1,649,986
2021-12-10 2021-12-08 PlS Planned sale
38,489 -27.3%
23.01
US$885,690
38,489 -27.3% 23.01 US$885,690
2021-12-10 2021-12-08 PlS Planned sale
36,511 -20.6%
22.56
US$823,626
36,511 -20.6% 22.56 US$823,626